Literature DB >> 187329

Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).

N Prajda, H P Morris, G Weber.   

Abstract

The behavior of the rate-limiting enzyme of purine catabolism, xanthine oxidase (EC 1.2.3.2); was examined in normal liver, in 17 hepatomas of different growth rates, and in rapidly growing differentiating and regenerating liver. Xanthine oxidase activity was measured in the supernatant fluid prepared by centrifugation of 5% homogenates at 100,000 X g for 30 min. There was no uricase activity in the supernatant fluid. The affinity of xanthine oxidase to xanthine was similar in normal liver and in slow- and rapidly growing hepatomas (Km=6 to 8 muM), and theoptimum pH was 8.0; at pH 7.4, the activity was 80% of that at the pH optimum. A standard assay was worked out for the liver and hepatoma systems; the enzyme activity was linear during 60-min incubation and proportionate with amounts of protein added over a range of 0.5 to 3.0 mg. Xanthine oxidase specific activity was 9 times higher in small intestine than in liver. Activities in lung, spleen, kidney, heart, testes, and thymus were 67, 59, 21, 19, 8, and 8%, and in skeletal muscle, brain, and bone marrow activities were 5% of that of the liver. In regenerating liver, xanthine oxidase activity was not changed from that of the liver of sham-operated controls up to 96 hr after operation. The activity of the average differentiating liver cell was less than 5% of that of adult liver during the first week after birth. At postnatal ages of 18, 25, 30 and 40 days, the activity rose to 18, 46, 76, and 94%, respectively, of that of the adult liver. In starvation, hepatic xanthine oxidase activity per cell was preferentially depleted as compared to the decline in protein concentration. Upon refeeding, the enzymatic activity was restored more slowly than the protein content. Since xanthine oxidase activity was decreased in all examined hepatomas, including the slowest-growing, well-differentiated neoplasms, the altered activity of this enzyme appears to be.linked with neoplastic transformatiobosyl 1-pyrophosphate amidotransferase (EC 2.4.2.14), was increassed in the hepatomas, the reprogramming of gene expression results in an imbalance that favors the synthetic over the catabolic potential. This enzymatic imbalance should confer selective advantages to the cancer cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187329

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.

Authors:  N Linder; C Haglund; M Lundin; S Nordling; A Ristimäki; A Kokkola; J Mrena; J-P Wiksten; J Lundin
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

2.  Redox cycling of Cu(II) by 6-mercaptopurine leads to ROS generation and DNA breakage: possible mechanism of anticancer activity.

Authors:  Sayeed Ur Rehman; Haseeb Zubair; Tarique Sarwar; Mohammed Amir Husain; Hassan Mubarak Ishqi; Shamshun Nehar; Mohammad Tabish
Journal:  Tumour Biol       Date:  2014-10-25

3.  Studies on the mechanism of action of 6-mercaptopurine. Interaction with copper and xanthine oxidase.

Authors:  U Kela; R Vijayvargiya
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

4.  C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.

Authors:  Yiting Wang; Shuang Liu; Shaoping Tian; Runxuan Du; Tianyu Lin; Xuesong Xiao; Rui Wang; Ruibing Chen; Hua Geng; Saravanan Subramanian; Yuanjie Niu; Yong Wang; Dan Yue
Journal:  Int J Med Sci       Date:  2022-05-09       Impact factor: 3.642

5.  Application of Surface-Enhanced Raman Spectroscopy in the Screening of Pulmonary Adenocarcinoma Nodules.

Authors:  Bowen Peng; Huan Yan; Runrui Lin; Gang Yin
Journal:  Biomed Res Int       Date:  2022-06-23       Impact factor: 3.246

6.  Partial purification, properties and regulation of inosine 5'phosphate dehydrogenase in normal and malignant rat tissues.

Authors:  R C Jackson; H P Morris; G Weber
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

7.  Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.

Authors:  I Durak; N Ormeci; O Akyol; O Canbolat; M Kavutçu; M Bülbül
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

Review 8.  Mechanistic insights into the treatment of iron-deficiency anemia and arthritis in humans with dietary molybdenum.

Authors:  Brian James Grech
Journal:  Eur J Clin Nutr       Date:  2021-01-29       Impact factor: 4.884

9.  Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology.

Authors:  Lambert C M Ngoka
Journal:  Proteome Sci       Date:  2008-10-24       Impact factor: 2.480

10.  Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues.

Authors:  R F Anderson; K B Patel; K Reghebi; S A Hill
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.